| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/19/2004 | US20040162312 NMDA NR2B antagonists for treatment |
| 08/19/2004 | US20040162294 Therapeutic use of selective PDE10 inhibitors |
| 08/19/2004 | US20040162274 Inhibition of steroid synthesis by use of progesterone or a progesterone receptor agonist |
| 08/19/2004 | US20040162273 Powder pharmaceutical compositions |
| 08/19/2004 | US20040162269 Administering a therapeutically effective amount of a formulation comprising:an inhibitor of nitric oxide synthase, and an aminosugar for therapy |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162254 Antiviral oligonucleotides targeting HSV and CMV |
| 08/19/2004 | US20040162253 Administering pharmacologically acceptable oligonucleotide at least 10 nucleotides in length, wherein the anti-HBV activity of oligonucleotide occurs principally by a non-sequence complementary mode of action |
| 08/19/2004 | US20040162248 Preparation and diabetic use of gibberellins |
| 08/19/2004 | US20040161825 Sperm specific proteins |
| 08/19/2004 | US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161797 for drug screening by assessing the effect on localization of signal transduction proteins, particularly the protein kinase C (PKC) isoenzymes |
| 08/19/2004 | US20040161481 Analgesics; in situ administering by injection or infiltration; concurretn with nsaid; side effect reduction- |
| 08/19/2004 | US20040161475 Anticancer, antitumor agents; ssynergistic mixtures with retinoic acid; olid tumors |
| 08/19/2004 | US20040161462 Sustained release; hypoglycemic agents; synergistic mixture |
| 08/19/2004 | US20040161443 Vehicle |
| 08/19/2004 | US20040161436 Skin treatment composition and method |
| 08/19/2004 | US20040161430 Dye-azide compounds for dual phototherapy |
| 08/19/2004 | US20040161428 Such as transferrin-doxorubicin conjugate linked by gluteraldehyde; inexpensive, effective |
| 08/19/2004 | US20040161422 Nutritional compositions comprising probiotics |
| 08/19/2004 | US20040161415 Inducted heat shock proteins in activated lymphocytes |
| 08/19/2004 | US20040161413 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 08/19/2004 | US20040161407 Medicinal compositions |
| 08/19/2004 | US20040161386 Pharmaceutical compositions based on anticholinergic and dopamine agonists |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | US20040160876 Method for determining a tilt angle of an optical pickup head |
| 08/19/2004 | DE10142663B4 C2-Disubstituierte Indan-1-ol-Systeme C2-Disubstituted indan-1-ol systems |
| 08/19/2004 | CA2515302A1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 08/19/2004 | CA2515294A1 Therapeutic agents for diabetes |
| 08/19/2004 | CA2515290A1 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides |
| 08/19/2004 | CA2515266A1 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2514334A1 Novel antiherpes drug combinations |
| 08/19/2004 | CA2513731A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/18/2004 | EP1447408A1 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and therapeutics produced therewith |
| 08/18/2004 | EP1447099A2 Antineoplastic polyethylene conjugates of cytostatic compounds and pharmaceuticals comprising same |
| 08/18/2004 | EP1447090A2 Use of hyaluronidase for preventing and treating cardiovascular diseases |
| 08/18/2004 | EP1447085A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 08/18/2004 | EP1446874A2 Microphone-tailored equalizing system |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446425A2 Treatment of micro-organism infection |
| 08/18/2004 | EP1446414A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 08/18/2004 | EP1446401A2 C-5 modified indazolylpyrrolotriazines |
| 08/18/2004 | EP1446396A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram |
| 08/18/2004 | EP1446388A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 08/18/2004 | EP1446170A1 Medical devices having antimicrobial coatings thereon |
| 08/18/2004 | EP1446160A1 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification |
| 08/18/2004 | EP1446153A1 Pharmaceutical composition comprising factor vii polypeptides and tissue plasminogen inhibitors |
| 08/18/2004 | EP1446152A1 Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors |
| 08/18/2004 | EP1446150A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
| 08/18/2004 | EP1446140A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446138A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446136A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/18/2004 | EP1446133A2 Methods of improving central nervous system functioning |
| 08/18/2004 | EP1446114A1 Compositions and methods for treating osteoporosis |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446104A1 Spray drying methods and compositions thereof |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446099A1 Injectable depot composition |
| 08/18/2004 | EP1446015A1 Remodeling of tissues and organs |
| 08/18/2004 | EP1446012A1 Combination bacteriolytic therapy for the treatment of tumors |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1395273A4 Targeted delivery of drugs for the treatment of viral infections |
| 08/18/2004 | EP1294366B1 Pharmaceutical compounds for treating copd |
| 08/18/2004 | EP1140837B1 Compounds useful in the treatment of inflammatory diseases |
| 08/18/2004 | EP1117390B1 Mucosal originated drug delivery systems |
| 08/18/2004 | EP1038025A4 Genetic alterations associated with cancer |
| 08/18/2004 | EP1037636A4 Inhibition of membrane-associated viral replication |
| 08/18/2004 | EP1012188B1 Composition for treating diabetes mellitus and obesity |
| 08/18/2004 | EP0706387B1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | CN1522303A Method for detecting a risk of hypertension and uses thereof |
| 08/18/2004 | CN1522244A Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/18/2004 | CN1522158A Treatment of parasitic disease |
| 08/18/2004 | CN1522149A Promoting whole body health |
| 08/18/2004 | CN1522145A Compositions and methods for treating vulvovaginitis and vaginosis |
| 08/18/2004 | CN1522144A Compositions for preventing human cancer and method of preventing human cancer |
| 08/18/2004 | CN1522139A Enhanced parmacokinetic profile of hydrophobic substances |
| 08/18/2004 | CN1522132A Composition for freshening nostrils and sinus cavities |
| 08/18/2004 | CN1520895A Sustained delivery of an active agent using an implantable system |
| 08/18/2004 | CN1520886A Application of mycoplasma-resistant pharmaceutical and P37 protein blocking agent in preparing antineoplastic medicine |
| 08/18/2004 | CN1520846A Quick-effective aerosol with plant aroma and its preparation |
| 08/18/2004 | CN1520827A Amino acid loaded trityl alcohol resins, method of producing same and use thereof |
| 08/18/2004 | CN1162156C Use of olanzapine and fluoxetine in preparing medicine for psychosis |
| 08/17/2004 | US6778854 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 08/17/2004 | US6777441 For therapy and prophylaxis |
| 08/17/2004 | US6777440 For therapy of hiv infections; for therapy of aids or arc |
| 08/17/2004 | US6777437 Antidepressants, anxiolytic agents. sexual disorders |
| 08/17/2004 | US6777424 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
| 08/17/2004 | US6777415 Administering (1) a farnesyl protein transferase inhibitor and (2) a tyrosine kinase inhibitor. |
| 08/17/2004 | US6777404 Use of corticotropin releasing factor antagonists and related compositions |
| 08/17/2004 | US6777399 Anti-inflammatory androstane derivative compositions |
| 08/17/2004 | US6777397 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/17/2004 | CA2334257C Treatment of osteoporosis with ep2/ep4 receptor selective agonists |